Dashboard
Manage Tickers

PULM Pulmatrix, Inc.

Nasdaq pulmatrix.com


$ 4.88 $ 0.17 (3.72 %)    

Friday, 17-Oct-2025 13:52:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 4.8128
$ 4.72
$ 4.59 x 1
$ 6.59 x 100
$ 4.67 - $ 4.96
$ 1.96 - $ 10.40
12,829
na
17.58M
$ 0.60
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-16-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-15-2025 03-31-2025 10-Q
4 03-21-2025 12-31-2024 10-K
5 11-08-2024 09-30-2024 10-Q
6 08-13-2024 06-30-2024 10-Q
7 05-10-2024 03-31-2024 10-Q
8 03-28-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-12-2023 03-31-2023 10-Q
12 03-30-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-10-2022 06-30-2022 10-Q
15 05-12-2022 03-31-2022 10-Q
16 03-29-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 08-10-2021 06-30-2021 10-Q
19 05-11-2021 03-31-2021 10-Q
20 03-23-2021 12-31-2020 10-K
21 11-12-2020 09-30-2020 10-Q
22 08-07-2020 06-30-2020 10-Q
23 05-14-2020 03-31-2020 10-Q
24 03-26-2020 12-31-2019 10-K
25 11-01-2019 09-30-2019 10-Q
26 08-05-2019 06-30-2019 10-Q
27 05-15-2019 03-31-2019 10-Q
28 02-19-2019 12-31-2018 10-K
29 11-14-2018 09-30-2018 10-Q
30 08-03-2018 06-30-2018 10-Q
31 05-11-2018 03-31-2018 10-Q
32 03-13-2018 12-31-2017 10-K
33 11-09-2017 09-30-2017 10-Q
34 08-04-2017 06-30-2017 10-Q
35 05-05-2017 03-31-2017 10-Q
36 03-10-2017 12-31-2016 10-K
37 11-04-2016 09-30-2016 10-Q
38 08-04-2016 06-30-2016 10-Q
39 05-05-2016 03-31-2016 10-Q
40 03-10-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

pulmatrix-mulls-divestment-of-clinical-assets-proprietary-isperse-technology-as-part-of-proposed-merger-with-cullgen
Pulmatrix Mulls Divestment Of Clinical Ass...
10/16/2025 12:17:42

As part of the proposed merger, Pulmatrix currently intends to divest its assets including its proprietary dry powder delivery ...

pulmatrix-q3-eps-024-up-from-071-yoy
Pulmatrix Q3 EPS $(0.24) Up From $(0.71) YoY
10/16/2025 12:14:01

Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.24) per share. This is a 66.2 percent increase over losses of $(0.71) ...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/13/2025 21:06:15

pulmatrix-q2-eps-042-up-from-159-yoy
Pulmatrix Q2 EPS $(0.42) Up From $(1.59) YoY
08/06/2025 12:16:07

Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.42) per share. This is a 73.58 percent increase over losses of $(1.59)...

pulmatrix-seeks-divestment-of-clinical-assets-and-isperse-inhalation-technology-amid-advancements-in-migraine-copd-and-antifungal-treatments
Pulmatrix Seeks Divestment Of Clinical Ass...
08/06/2025 12:15:17

Pulmatrix Currently Seeking Divestment of Clinical Assets and Proprietary iSPERSE™ TechnologyiSPERSE™ TechnologyiSPERSE™ partic...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/01/2025 12:07:35

pulmatrix-q1-eps-050-down-from-023-yoy
Pulmatrix Q1 EPS $(0.50) Down From $0.23 YoY
05/15/2025 12:21:14

Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.50) per share. This is a 317.39 percent decrease over earnings of $0.2...

pulmatrix-fy24-eps-262-up-from-387-yoy-revenue-78m-up-from-73m-yoy
Pulmatrix FY24 EPS $(2.62) Up From $(3.87)...
03/21/2025 12:11:00

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
03/18/2025 21:05:47

trading-halt-halt-status-updated-at-94500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 9:45:...
11/13/2024 14:45:04

pulmatrix-and-cullgen-announce-proposed-merger-pre-merger-pulmatrix-stockholers-to-own-36-of-combined-company-pre-merger-cullgen-stockholders-to-own-964-of-combined-company-under-name-cullgen
Pulmatrix And Cullgen Announce Proposed Me...
11/13/2024 14:04:49

Merger to create a Nasdaq-listed company focusing on targeted protein degradation technology with three degrader programs in or...

trading-halt-halted-at-85500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 8:55:00 a.m. ET - ...
11/13/2024 13:55:03

pulmatrix-q3-eps-071-up-from-103-yoy-sales-36600k-down-from-175m-yoy
Pulmatrix Q3 EPS $(0.71) Up From $(1.03) Y...
11/08/2024 13:08:08

Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.71) per share. This is a 31.07 percent increase over losses of $(1.03)...

pulmatrix-q2-2024-revenue-155m-vs-18m-yoy-eps-159-vs-104-yoy
Pulmatrix Q2 2024 Revenue $1.55M Vs $1.8M ...
08/13/2024 13:07:30

Core News & Articles
Pulmatrix Enters Cross License Agreement W...
05/29/2024 12:49:00

pulmatrix-files-for-mixed-shelf-of-upto-95m
Pulmatrix Files For Mixed Shelf Of Upto $95M
05/17/2024 20:08:58

- SEC Filing

pulmatrix-announces-peer-reviewed-publication-headache-the-journal-of-head-and-face-pain-clinical-results-for-its-orally-inhaled-dhe-for-acute-migraine
Pulmatrix Announces Peer-Reviewed Publicat...
05/15/2024 13:31:53

Orally Inhaled PUR3100 is associated with rapid systemic PK within the therapeutic window and a mean time to Cmax matching intr...

pulmatrix-q1-2024-eps-023-up-from-122-yoy-revenue-5885m-up-from-1499m-yoy
Pulmatrix Q1 2024 EPS $0.23 Up From $(1.22...
05/10/2024 12:08:57

pulmatrix-q4-eps-057-beats-104-estimate-sales-220m-beat-177m-estimate
Pulmatrix Q4 EPS $(0.57) Beats $(1.04) Est...
03/29/2024 03:27:52

Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(1.04) by ...

pulmonx-sees-fy24-revenue-81m-84m
Pulmonx Sees FY24 Revenue $81M-$84M
02/21/2024 22:19:39

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION